US Patent Issued to Genfleet Therapeutics (Shanghai), Zhejiang Genfleet Therapeutics on June 30 for "Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,559, issued on June 30, was assigned to Genfleet Therapeutics (Shanghai) Inc. (Shanghai) and Zhejiang Genfleet Therapeutics Co. Ltd. (Zhejiang, China).

"Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof" was invented by Fusheng Zhou (Shanghai), Xiaoming Xu (Shanghai), Leitao Zhang (Shanghai), Xin Li (Shanghai), Lili Tang (Shanghai) and Jiong Lan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a dihydronaphthyridinone compound as shown in formula (I), which compound has a selective inhibitory effect on RIPK1, and a pharmaceutically acceptable salt, a stereoisomer, a solvate or a prodrug the...